Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883396 · ClinicalTrials.gov registry record
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
A clinical trial of Patellar Dislocation and Patellar Dislocation, Recurrent, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- 850
- Enrollment target
- 16
- Study locations
NCT06883396 is a study of Patellar Dislocation and Patellar Dislocation, Recurrent that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 850 participants, above the 113-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (652% higher). The trial reports 16 study locations across 11 states.
The verdict
NCT06883396, a study of Patellar Dislocation and Patellar Dislocation, Recurrent, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- 850 participants
- Enrollment target
- 16
- Study locations
Study Summary
The goal of this observational study is to learn about the outcomes of medial patellofemoral ligament (MPFL) reconstruction for the treatment of recurrent patellar instability. The main questions it aims to answer are: * What are the risk factors for recurrent patellar instability after MPFL reconstruction? * What functional outcomes do patients report after MPFL reconstruction? Participants undergoing MPFL reconstruction will answer survey questions about their knee and activity level 1 year and 2 years after surgery.
Conditions Studied
Interventions
- PROCEDURE Medial Patellofemoral Ligament (MPFL) Reconstruction
Study Locations (16)
New York
- Mount Sinai - New York
- NYU Langone Health - New York
- Hospital for Special Surgery - New York
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Cleveland Clinic - Cleveland
- Ohio State University Wexler Medical Center - Dublin
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
California
- Stanford University - Redwood City
Florida
- University of Florida - Gainesville
Illinois
- Midwest Orthopaedics at Rush - Chicago
Iowa
- University of Iowa - Iowa City
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06883396
The ClinicalTrials.gov registry entry for NCT06883396 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 850 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (652% higher). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Patellar Dislocation appearing as the primary indexed condition, and to 1 intervention - of which Medial Patellofemoral Ligament (MPFL) Reconstruction is the first listed.
NCT06883396 reports 16 study locations spanning 11 distinct geographic areas - top geographies include New York, Ohio, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06883396 about?
NCT06883396 is a clinical study titled "JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction". The goal of this observational study is to learn about the outcomes of medial patellofemoral ligament (MPFL) reconstruction for the treatment of recurrent patellar instability. The main questions it aims to answer are: * What are the risk factors for recurrent patellar instability after MPFL recons...
What is the current status of trial NCT06883396?
This trial is currently recruiting. The enrollment target is 850 participants. The study started on 2023-01-01. Estimated completion is 2027-12.
What conditions does trial NCT06883396 study?
This clinical trial studies the following conditions: Patellar Dislocation, Patellar Dislocation, Recurrent, Patellar Instability, Patellofemoral Dislocation, Patellofemoral Joint Dislocation.
What interventions are being tested in trial NCT06883396?
The interventions under investigation include: Medial Patellofemoral Ligament (MPFL) Reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT06883396?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06883396 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patellar Dislocation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood Flow Restriction Training After Patellar INStability
RECRUITING · NA
-
Effect of Early Range of Motion Following First Time Patellar Dislocation
ACTIVE NOT RECRUITING · NA
-
The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.